CARES Act: OTC Pathway for Novel Drug Dosage Form Technologies

With the advent of the CARES Act, new technologies that could be used in drug development and the creation of novel dosage forms for over-the-counter drugs will open opportunities for creators and developers.  Join us for a webinar that will explore options that will allow them to take their creations to market in a potentially faster and simpler way than the New Drug Application process. 

Topics will include:

• Administrative Order process for drugs, a new FDA process created by the CARES Act
• Differences from the current OTC Monograph process
• Opportunities and pathway for development of novel technologies, including new OTC drug dosage forms
• Preparing OTC Monograph Order Request (OMOR) Submissions